Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP817573.RAcft1vriQhbNlw7Zhh4v1EGdXXPM7oLWcATjtWy2_0uQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP817573.RAcft1vriQhbNlw7Zhh4v1EGdXXPM7oLWcATjtWy2_0uQ130_assertion type Assertion NP817573.RAcft1vriQhbNlw7Zhh4v1EGdXXPM7oLWcATjtWy2_0uQ130_head.
- NP817573.RAcft1vriQhbNlw7Zhh4v1EGdXXPM7oLWcATjtWy2_0uQ130_assertion description "[The sensitization by ALC was reflected in an improved in vivo antitumor efficacy of the combination over cisplatin alone in wild-type p53 lung tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817573.RAcft1vriQhbNlw7Zhh4v1EGdXXPM7oLWcATjtWy2_0uQ130_provenance.
- NP817573.RAcft1vriQhbNlw7Zhh4v1EGdXXPM7oLWcATjtWy2_0uQ130_assertion evidence source_evidence_literature NP817573.RAcft1vriQhbNlw7Zhh4v1EGdXXPM7oLWcATjtWy2_0uQ130_provenance.
- NP817573.RAcft1vriQhbNlw7Zhh4v1EGdXXPM7oLWcATjtWy2_0uQ130_assertion SIO_000772 20562210 NP817573.RAcft1vriQhbNlw7Zhh4v1EGdXXPM7oLWcATjtWy2_0uQ130_provenance.
- NP817573.RAcft1vriQhbNlw7Zhh4v1EGdXXPM7oLWcATjtWy2_0uQ130_assertion wasDerivedFrom befree-20140225 NP817573.RAcft1vriQhbNlw7Zhh4v1EGdXXPM7oLWcATjtWy2_0uQ130_provenance.
- NP817573.RAcft1vriQhbNlw7Zhh4v1EGdXXPM7oLWcATjtWy2_0uQ130_assertion wasGeneratedBy ECO_0000203 NP817573.RAcft1vriQhbNlw7Zhh4v1EGdXXPM7oLWcATjtWy2_0uQ130_provenance.